Is $1 Billion in Sales in the Cards for Canopy Growth Corp (TSX:WEED)?

Projections suggest Canopy Growth Corp (TSX:WEED)(NYSE:CGC) could hit $1 billion in revenue within 18 months. If so, what does that mean for valuation?

| More on:

Early in 2019, two of my Foolish colleagues have already asked whether Canopy Growth (TSX:WEED)(NYSE:CGC) stock can hit $70 and $100 by the end of 2019.

Even with the stock’s 32% gain over the past five days, it’s still 40% away from $70 and 100% from $100. Given the volatility of WEED, it could just as quickly decline 32% over the next five days, making it impossible to predict.

What we do know is that incoming Constellation Brands (NYSE:STZ) CEO Bill Newlands believes that Canopy Growth can reach its target of $1 billion revenue run rate within 18 months.

Here’s what he said in Constellation’s Q3 2018 conference call:

Canopy continues to focus on intellectual property development across medical and recreational opportunities while also preparing and creating brands and products for new, legal recreational cannabis markets across various product formats that will be sold through new and existing channels.”

“It is these initiatives that give me confidence that Canopy can and will achieve their CAD 1 billion revenue run rate target within the next 18 months.”

Now that’s something to work a valuation around.

How many times sales?

Canopy had $49.2 million in revenue through the first two quarters of fiscal 2019, which was 47% higher than a year earlier. Annualize those sales and you get a run rate of $98 million.

At a current market cap of $16.9 billion, Canopy is trading at 172 times sales, a ridiculous amount, but not unheard of for growth companies in burgeoning industries.

To get to $1 billion in 18 months from where it currently sits, it needs to grow sales 52% a quarter for the next seven quarters.

Given that edibles and cannabis-infused drinks become legal in Canada in October, I think it’s entirely realistic for Canopy and Newlands to believe in its $1 billion target.

Who knows? It might even turn out to be a conservative prediction.

So, back to the valuation question and the P/S ratio.

Let’s assume that Canopy grows revenues by 52% a quarter for the next seven quarters. At 52 times revenue, Canopy would have a valuation of $93.6 billion. That’s an upside of 454% over just 18 months.

Is 52 times sales in 18 months a valid multiple?

It might be if it can also generate profits from the $1.8 billion, but that’s unlikely, so let’s cut the P/S ratio in half to 26 times, which gives us a market cap of $46.8 billion — a very attractive 177% upside over 18 months.

The current share price should be….?

Let’s assume that Canopy does hit $1.8 billion in sales in June 2020 with a market cap of $46.8 billion.

Shouldn’t the company’s market cap be higher than $16.9 billion today? Using a 10% discount to determine the present value, which is pretty high, today’s market cap would be $40.2 billion.

However, this assumes that the $1.8 billion in revenue is in the bag. It also assumes that investors aren’t going to penalize the stock for not making money on those sales. That’s an assumption we shouldn’t make.

In my estimation, the intrinsic value of Canopy stock today is somewhere between $40 billion and $16.9 billion.

With approximately 339.8 million shares outstanding, a $70 share price translates to a $23.8 billion market cap; a $100 share price translates to a $34.0 billion market cap.

If I were to guess, Canopy’s true value today would be between $80 and $85 per share.

But the real question remains: Will Canopy Growth reach $1.8 billion in revenue within 18 months? I believe it will.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned.

More on Investing

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »

Businessman holding AI cloud
Tech Stocks

Could Investing $20,000 in Nvidia Make You a Millionaire?

Nvidia stock has made investors millionaires in the last 10 years. Is it too late to invest to become a…

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »

money cash dividends
Stocks for Beginners

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

If you're looking for cheap stocks, these three have a huge future ahead of them, all while costing far less…

Read more »